Pulmonary vascular disease & thromboembolismMeta-analysis
Clinical Utility of Patient-Reported Outcome Instruments in the Management of Pulmonary Hypertension
- Systematic review
Authors' conclusion
EmPHasis-10 demonstrated strong psychometric properties and the greatest feasibility for clinical use.
Study context
- Population
- Patient-reported outcome measures (PROM) developed and validated for pulmonary hypertension (PH) (pulmonary arterial hypertension (PAH) and CTEPH), MEDLINE papers January 1, 2006, to October 1, 2022papers retrieved
- Participants
- 527 participants
- Comparison
- PH-specific PROM instruments compared by psychometric criteria
Pooled result
As reported in the abstract
Psychometric properties and feasibility of PH-specific PROM
PROM identified
35
Disease-specific instruments in final analysis
5
Original publication
Clinical Utility of Patient-Reported Outcome Instruments in the Management of Pulmonary Hypertension. JACC Heart Fail. Published 25 October 2023. doi:10.1016/j.jchf.2023.09.008
Summarised from the published abstract; every number is checked against it